Trobalt will be manufactured under the trade name Potiga in the US and Canada. The drug is likely to be launched in the US in the first quarter of 2012.
-
Trobalt (ezogabine/retigabine) is indicated for the treatment of... -
Trobalt is a potassium channel agent which activates the KCNQ channels and... -
The European Medicines Agency approved Trobalt in March 201, based on the... -
Trobalt will be manufactured under the trade name Potiga in the US and...
